AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/102

Authors: ALLAVENA P GIARDINA G SEN S COLELLA G BROGGINI M DINCALCI M
Citation: P. Allavena et al., IFN-BETA PARTIALLY COUNTERACTS INHIBITION OF NATURAL-KILLER ACTIVITY-INDUCED BY SOME ANTITUMOR AGENTS, Journal of interferon & cytokine research, 18(2), 1998, pp. 87-93

Authors: VALOTI G NICOLETTI MI PELLEGRINO A JIMENO J HENDRIKS H DINCALCI M FAIRCLOTH G GIAVAZZI R
Citation: G. Valoti et al., ECTEINASCIDIN-743, A NEW MARINE NATURAL PRODUCT WITH POTENT ANTITUMOR-ACTIVITY ON HUMAN OVARIAN-CARCINOMA XENOGRAFTS, Clinical cancer research, 4(8), 1998, pp. 1977-1983

Authors: CODEGONI AM NICOLETTI MI BURAGGI G VALOTI G GIAVAZZI R DINCALCI M LANDONI F MANEO A BROGGINI M
Citation: Am. Codegoni et al., MOLECULAR CHARACTERIZATION OF A PANEL OF HUMAN OVARIAN-CARCINOMA XENOGRAFTS, European journal of cancer, 34(9), 1998, pp. 1432-1438

Authors: DINCALCI M BONFANTI M PIFFERI A MASCELLANI E TAGLIABUE G BERGER D FIEBIG HH
Citation: M. Dincalci et al., THE ANTITUMOR-ACTIVITY OF ALKYLATING-AGENTS IS NOT CORRELATED WITH THE LEVELS OF GLUTATHIONE, GLUTATHIONE TRANSFERASE AND O-6-ALKYLGUANINE-DNA-ALKYLTRANSFERASE OF HUMAN TUMOR XENOGRAFTS, European journal of cancer, 34(11), 1998, pp. 1749-1755

Authors: DAMIA G GUIDI G DINCALCI M
Citation: G. Damia et al., EXPRESSION OF GENES INVOLVED IN NUCLEOTIDE EXCISION-REPAIR AND SENSITIVITY TO CISPLATIN AND MELPHALAN IN HUMAN CANCER CELL-LINES, European journal of cancer, 34(11), 1998, pp. 1783-1788

Authors: DONELLI MG ZUCCHETTI M MUNZONE E DINCALCI M CROSIGNANI A
Citation: Mg. Donelli et al., PHARMACOKINETICS OF ANTICANCER AGENTS IN PATIENTS WITH IMPAIRED LIVER-FUNCTION, European journal of cancer, 34(1), 1998, pp. 33-46

Authors: SOTTANI C MINOIA C DINCALCI M PAGANINI M ZUCCHETTI M
Citation: C. Sottani et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY TANDEM MASS-SPECTROMETRY PROCEDURE WITH AUTOMATED SOLID-PHASE EXTRACTION SAMPLE PREPARATION FOR THE QUANTITATIVE-DETERMINATION OF PACLITAXEL (TAXOL(R)) IN HUMAN PLASMA, Rapid communications in mass spectrometry, 12(5), 1998, pp. 251-255

Authors: DINCALCI M
Citation: M. Dincalci, SOME HOPE FROM MARINE NATURAL-PRODUCTS, Annals of oncology, 9(9), 1998, pp. 937-938

Authors: ZUCCHETTI M BOIARDI A SILVANI A PARISI I PICCOLROVAZZI S DINCALCI M
Citation: M. Zucchetti et al., DAUNORUBICIN AND DAUNORUBICINOL LEVELS IN HUMAN GLIOMA TUMORS AFTER ADMINISTRATION OF LIPOSOMAL ENCAPSULATED DAUNORUBICIN (DAUNOXOME), Annals of oncology, 9, 1998, pp. 617-617

Authors: CODEGONI AM CASTAGNA S MANGIONI C SCOVASSI AI BROGGINI M DINCALCI M
Citation: Am. Codegoni et al., DNA-TOPOISOMERASE-I ACTIVITY AND CONTENT IN EPITHELIAL OVARIAN-CANCER, Annals of oncology, 9(3), 1998, pp. 313-319

Authors: GHIELMINI M COLLI E BOSSHARD G ZUCCHETTI M DINCALCI M GERONI C SESSA C
Citation: M. Ghielmini et al., EVALUATION OF THE HEMATOTOXIC POTENTIAL OF METHOXYMORPHOLINYL-DOXORUBICIN (MMDX) METABOLITES IN PATIENTS PLASMA BY CLONOGENIC ASSAYS ON HEMATOPOIETIC PROGENITOR CELLS, Annals of oncology, 9, 1998, pp. 206-206

Authors: SESSA C ZUCCHETTI M BAUER J NAEGELE H DINCALCI M GHIELMINI M ROSSI S VANDENBULCKE T PACCIARINI M DOMENIGONI L CAVALLI F
Citation: C. Sessa et al., PHASE-I CLINICAL AND PHARMACOKINETIC (PK) STUDY OF ORAL (PO) METHOXY-MORPHOLINO DOXORUBICIN (PNU-152243) ON A SINGLE INTERMITTENT SCHEDULE, Annals of oncology, 9, 1998, pp. 450-450

Authors: MANTONVANI R LAVALLE E BONFANTI M SOUSAFARO JMF FAIRCLOTH G DINCALCI M
Citation: R. Mantonvani et al., EFFECT OF ECTEINASCIDIN-743 (ET-743) ON THE INTERACTION BETWEEN TRANSCRIPTION FACTORS AND DNA, Annals of oncology, 9, 1998, pp. 534-534

Authors: ERBA E BERGAMASCHI D RONZONI S FARETTA M BASSANO L CAPPELLA P VALOTI G GIAVAZZI R JIMENO J FAIRCLOTH G DINCALCI M
Citation: E. Erba et al., MODE OF ACTION OF ECTEINASCIDIN-743, A NATURAL MARINE COMPOUND WITH ANTITUMORAL ACTIVITY, Annals of oncology, 9, 1998, pp. 535-535

Authors: ERBA E BERGAMASCHI D RONZONI S FARETTA M BASSANO L VIKHANSKAYA F JIMENO J FAIRCLOTH G CATAPANO CV DINCALCI M
Citation: E. Erba et al., THIOCORALINE, A NOVEL DNA-POLYMERASE INHIBITOR WITH A HIGHER CYTOTOXIC POTENCY AGAINST CANCER-CELLS WITH MUTATED OR INACTIVATED P53, Annals of oncology, 9, 1998, pp. 542-542

Authors: GHIELMINI M COLLI E BOSSHARD G PENNELLA G GERONI C TORRI V DINCALCI M CAVALLI F SESSA C
Citation: M. Ghielmini et al., HEMATOTOXICITY ON HUMAN BONE MARROW-DERIVED AND UMBILICAL-CORD BLOOD-DERIVED PROGENITOR CELLS AND IN-VITRO THERAPEUTIC INDEX OF METHOXYMORPHOLINYLDOXORUBICIN AND ITS METABOLITES, Cancer chemotherapy and pharmacology, 42(3), 1998, pp. 235-240

Authors: CORSINI C MANCUSO P GHIELMINI M ZUCCHETTI M TEALDO F COCOROCCHIO E FERRUCCI PF PECCATORI F DINCALCI M MARTINELLI G
Citation: C. Corsini et al., INHIBITION OF CFU-GM GROWTH BY IDARUBICINOL CONTAINING PLASMA SAMPLESOBTAINED FROM POOR-PROGNOSIS LYMPHOMA PATIENTS TREATED WITH 3-DAYS INFUSION IDARUBICIN, Experimental hematology, 26(8), 1998, pp. 378-378

Authors: MARCHINI S COZZI P BERIA I GERONI C CAPOLONGO L DINCALCI M BROGGINI M
Citation: S. Marchini et al., SEQUENCE-SPECIFIC DNA ALKYLATION OF NOVEL TALLIMUSTINE DERIVATIVES, Anti-cancer drug design, 13(3), 1998, pp. 193-205

Authors: COLELLA G VIKHANSKAYA F CODEGONI AM BONAZZI C DINCALCI M BROGGINI M
Citation: G. Colella et al., HMLH1 AND HMSH2 EXPRESSION AND BAX FRAMESHIFT MUTATIONS IN OVARIAN-CANCER CELL-LINES AND TUMORS, Carcinogenesis, 19(4), 1998, pp. 691-694

Authors: VIKHANSKAYA F VIGNATI S BECCAGLIA P OTTOBONI C RUSSO P DINCALCI M BROGGINI M
Citation: F. Vikhanskaya et al., INACTIVATION OF P53 IN A HUMAN OVARIAN-CANCER CELL-LINE INCREASES THESENSITIVITY TO PACLITAXEL BY INDUCING G2 M ARREST AND APOPTOSIS/, Experimental cell research, 241(1), 1998, pp. 96-101

Authors: BERGAMASCHI D FARETTA M RONZONI S TAVERNA S DEFEUDIS P BONFANTI M GUIDI G FAIRCLOTH M JIMENO J DINCALCI M ERBA E
Citation: D. Bergamaschi et al., FLOW CYTOMETRIC ANALYSIS OF CELL-CYCLE PHASE PERTURBATIONS INDUCED BYTHIOCORALINE, A NEM MARINE-DERIVED ANTICANCER COMPOUND, European journal of histochemistry, 41, 1997, pp. 63-64

Authors: FARETTA M BERGAMASCHI D RONZONI S DINCALCI M ERBA E
Citation: M. Faretta et al., DIFFERENCES IN CYCLIN B1 EXPRESSION IN CELLS BLOCKED IN THE G2M PHASEAFTER TREATMENT WITH ANTICANCER AGENT - NEW 3-PARAMETRIC FLOW CYTOMETRIC ANALYSIS, European journal of histochemistry, 41, 1997, pp. 73-74

Authors: FAIRCLOTH G JIMENO J DINCALCI M
Citation: G. Faircloth et al., BIOLOGICAL-ACTIVITY OF THIOCORALINE, A NOVEL MARINE DEPSIPEPTIDE, European journal of cancer, 33, 1997, pp. 781-781

Authors: TAGLIABUE G FILIPPINI C UBEZIO P DINCALCI M
Citation: G. Tagliabue et al., COMBINATION OF THE NEW MINOR-GROOVE ALKYLATOR TALLIMUSTINE AND MELPHALAN, European journal of cancer, 33(2), 1997, pp. 284-287

Authors: SOTTANI C MINOIA C COLOMBO A ZUCCHETTI M DINCALCI M FANELLI R
Citation: C. Sottani et al., STRUCTURAL CHARACTERIZATION OF MONOHYDROXYLATED AND DIHYDROXYLATED METABOLITES OF PACLITAXEL IN RAT BILE USING LIQUID-CHROMATOGRAPHY ION-SPRAY TANDEM MASS-SPECTROMETRY, Rapid communications in mass spectrometry, 11(9), 1997, pp. 1025-1032
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>